Patanjali launches Covid-19 drugs | Coronil

Patanjali Ayurved Ltd, the company promoted by yoga guru Ramdev, has been asked by the government to provide details of the medicines launched by it as an alleged treatment for the patients of coronavirus disease (Covid-19) patients.

The ministry of Ayurveda, Yoga & Naturopathy, Unani, Siddha and Homoeopathy (AYUSH) has ordered Patanjali to stop advertising the products—Coronil and Swasari.

The ministry asked Patanjali to submit details of the sample size, sites and hospitals where the research study was conducted and also for the Institutional Ethics Committee clearance.

“Patanjali Ayurved Ltd has been asked to provide at the earliest details of the name and composition of the medicines being claimed for COVID treatment; site(s)/hospital(s), where the research study was conducted for COVID-19; protocol, sample size, Institutional Ethics Committee clearance, CTRI registration and results data of the study (ies) and stop advertising/publicizing such claims till the issue is duly examined,” the ministry said in its statement.

Here is what Patanjali said:

* Ramdev’s associate Acharya Balakrishna has claimed that the Centre has been provided with all the necessary details of the clinical trials of Coronil—the medicine launched on Tuesday by Patanjali.

* Balakrishna tweeted to claim that 100% parameters laid down for controlled trial of the Ayurvedic product have been followed by the company after Patanjali.

* The products have been made in association with privately-owned National Institute of Medical Science in Jaipur, according to Patanjali.

* Ramdev had claimed that the first clinical controlled study was conducted on 280 patients in Delhi and Ahmedabad among many other cities.